MYC and osteosarcoma: Systematically cell mapping by scRNA-seq analysis revealed the stem-like population in chemotherapy-resistant osteosarcoma having stem cell marker CD117, MYC oncogene, epigenetic regulator JMJD3, and angiogenesis marker VEGFR2.